KEYTRUDA (pembrolizumab) injection
KEYTRUDA is a brand-name prescription medication that’s used to treat reast cancer, Cervical cancer, Classic Hodgkin lymphoma, Cutaneous squamous cell carcinoma (a type of skin cancer), Endometrial carcinoma, Esophageal or gastroesophageal junction cancer and more. Brand Name: KEYTRUDA (pembrolizumab) injection, for intravenous use Initial U.S. Approval: 2014
Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!
For Overseas Patient/ Export inquires.
Call / WhatsApp Number
+91 9643240915 (Mr. Yashpal Singh)
+91 9289711087 (Ms. Sana Sadyar)
For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.
KEYTRUDA (pembrolizumab) injection
Pembrolizumab is approved to treat: Breast cancer, Cervical cancer, Classic Hodgkin lymphoma, Cutaneous squamous cell carcinoma (a type of skin cancer), Endometrial carcinoma, Esophageal or gastroesophageal junction cancer, Gastric (stomach) cancer or gastroesophageal junction adenocarcinoma, Hepatocellular carcinoma (a type of liver cancer), Melanoma, , Merkel cell carcinoma, Microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) cancer, Non-small cell lung cancer, Primary mediastinal large B-cell lymphoma, Renal cell carcinoma (a type of kidney cancer), Solid tumors , Squamous cell carcinoma of the head and neck, Urothelial carcinoma. Pembrolizumab is also being studied in the treatment of other types of cancer.
Keytruda, A drug that binds to the protein PD-1 to help immune cells kill cancer cells better and is used to treat many different types of cancer. These include cancers that express the protein PD-L1, that have certain mutations (changes) in genes involved in DNA repair, or that have a high number of tumor mutations. Keytruda is used alone or with other drugs to treat certain types of breast cancer, skin cancer (squamous cell carcinoma of the skin, Merkel cell carcinoma, and melanoma), colorectal cancer, endometrial cancer, renal cell carcinoma (a type of kidney cancer), esophageal cancer, gastroesophageal junction cancer, stomach cancer, non-small cell lung cancer, hepatocellular carcinoma (a type of liver cancer), cervical cancer, urothelial carcinoma (a type of bladder or urinary tract cancer), Hodgkin lymphoma, primary mediastinal large B-cell lymphoma, head and neck cancer, and other solid tumors. It is also being studied in the treatment of other types of cancer. Keytruda may block PD-1 and help the immune system kill cancer cells. It is a type of monoclonal antibody and a type of immune checkpoint inhibitor. Also called pembrolizumab.
pembrolizumab, A drug that binds to the protein PD-1 to help immune cells kill cancer cells better and is used to treat many different types of cancer. These include cancers that express the protein PD-L1, that have certain mutations (changes) in genes involved in DNA repair, or that have a high number of tumor mutations. Pembrolizumab is used alone or with other drugs to treat certain types of breast cancer, skin cancer (squamous cell carcinoma of the skin, Merkel cell carcinoma, and melanoma), colorectal cancer, endometrial cancer, renal cell carcinoma (a type of kidney cancer), esophageal cancer, gastroesophageal junction cancer, stomach cancer, non-small cell lung cancer, hepatocellular carcinoma (a type of liver cancer), cervical cancer, urothelial carcinoma (a type of bladder or urinary tract cancer), Hodgkin lymphoma, primary mediastinal large B-cell lymphoma, head and neck cancer, and other solid tumors. It is also being studied in the treatment of other types of cancer. Pembrolizumab may block PD-1 and help the immune system kill cancer cells. It is a type of monoclonal antibody and a type of immune checkpoint inhibitor. Also called Keytruda. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pembrolizumab
Drug (Brand / Generic): KEYTRUDA / pembrolizumab injection
Current Indications: Breast cancer, Cervical cancer, Classic Hodgkin lymphoma
Marketed by:: Merck Sharp & Dohme LLC
Approval Date: 2015
Available as (Form & Strength): Injection: 100 mg/4 mL (25 mg/mL) solution in a single-dose vial
For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here
Alleviare Life Sciences
About Us
Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.
Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.
Alleviare India is certified pharmaceutical facilitator / supplier / importer based in india. They are also who GDP certified. One of the pharmaceutical products they offer is “KEYTRUDA (pembrolizumab) injection”.
Confirmation of the order for KEYTRUDA (pembrolizumab) injection will be subject to the submission of a valid doctor’s prescription and, if applicable, an import permit.
We have delivered medicines to following cities in India – Ahmedabad, Aizawal, Aurangabad, Barshi, Bengaluru, Bhopal, Cachar, Chennai, Dibrugarh, Hyderabad, Karungapally, Kohima, Kollam, Kolkata, Mumbai, Meghalaya, Mizoram, Sikkim, Nagpur, New Delhi, Pondichery, Pune, Punjab, Thirunananthapuram, Tripura, Wardha
ALS serves as a facilitator, supplier & exporter in India assisting patients, doctors, and hospitals in importing the prescription medicine brand KEYTRUDA (pembrolizumab) injection. The import process requires a valid prescription and an Import License in the Patient’s Name.
For patients from following foreign countries seeking access to KEYTRUDA (pembrolizumab) injection, they can inquire and find further information by sending their inquiries to ALS.
We have delivered medicines to following countries – Argentina, Australia, Austria, Azerbaijan, Bahrain, Brazil, Bulgaria, Cambodia, Canada, Chile, Colombia, Costa Rica, Croatia, Cyprus, Denmark, Dominican Republic, Estonia, Finland, France, Georgia, Germany, Ghana, Greece, Guatemala, India, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kenya, Kuwait, Latvia, Lebanon, Libya, Lithuania, Malawi, Mexico, Montenegro, Nepal, Netherlands, New Zealand, Nigeria, Norway, Oman, Pakistan, Paraguay, Peru, Poland, Qatar, Romania, Saudi Arabia, Serbia, Singapore, Slovenia, Spain, Sri Lanka, Sweden, Switzerland, United Arab Emirates, United Kingdom, United States, Venezuela, Zimbabwe.
Kindly reach out to us for KEYTRUDA (pembrolizumab) injection price and availability confirmation.
The price of the medicines is the cost set by the manufacturer. In addition, Named Patient support fee, shipping costs and any local tax (if applicable) will apply.
